HEALTH CATALYST, INC. (HCAT) Shareholders’ equity 2017–2025
HEALTH CATALYST, INC. (HCAT) shareholders’ equity at each fiscal year-end, per SEC filings.
$245.8MFY2025 · since FY2017: -$259.5M → $245.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $245.8M | -32.7% |
| FY2024 | $365.2M | -0.5% |
| FY2023 | $366.9M | -13.7% |
| FY2022 | $425.0M | -18.6% |
| FY2021 | $522.1M | +89.1% |
| FY2020 | $276.1M | +37.6% |
| FY2019 | $200.6M | +153.5% |
| FY2018 | -$374.8M | -44.4% |
| FY2017 | -$259.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice